BioCentury | Sep 9, 2020
Deals

‘Transformational’ deal with Bayer, $239M series D expand Recursion’s reach into fibrosis

...rounds —Casdin Capital, Catalio Capital Management, Laurion Capital Management...
BioCentury | Mar 28, 2020
Management Tracks

Bernard joins Qiagen as CEO; plus CytomX, Recursion, 89bio, Heptares, Fusion, Freeline, Cognition, I-Mab, Seres and more

...Secora as CFO. He was managing director and head of capital markets and venture at Laurion Capital Management...
BioCentury | May 20, 2019
Financial News

May 20 Financial Quick Takes: Schrödinger tops off E round; plus Mabpharm IPO update, DNA Script, ADMA Biologics, Storm

...platform and expand its discovery pipeline. New investors participating include Invus, Pavilion Capital, Tubus Management, Laurion Capital Management...
BioCentury | Apr 1, 2019
Financial News

SpringWorks raises $125M series B round

...Healthcare Investments, BVF Partners, Surveyor Capital, Samsara BioCapital, ArrowMark Partners, GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and Laurion Capital Management...
Items per page:
1 - 4 of 4
BioCentury | Sep 9, 2020
Deals

‘Transformational’ deal with Bayer, $239M series D expand Recursion’s reach into fibrosis

...rounds —Casdin Capital, Catalio Capital Management, Laurion Capital Management...
BioCentury | Mar 28, 2020
Management Tracks

Bernard joins Qiagen as CEO; plus CytomX, Recursion, 89bio, Heptares, Fusion, Freeline, Cognition, I-Mab, Seres and more

...Secora as CFO. He was managing director and head of capital markets and venture at Laurion Capital Management...
BioCentury | May 20, 2019
Financial News

May 20 Financial Quick Takes: Schrödinger tops off E round; plus Mabpharm IPO update, DNA Script, ADMA Biologics, Storm

...platform and expand its discovery pipeline. New investors participating include Invus, Pavilion Capital, Tubus Management, Laurion Capital Management...
BioCentury | Apr 1, 2019
Financial News

SpringWorks raises $125M series B round

...Healthcare Investments, BVF Partners, Surveyor Capital, Samsara BioCapital, ArrowMark Partners, GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and Laurion Capital Management...
Items per page:
1 - 4 of 4